Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 272 (LINC00272) is a long intergenic non-coding RNA (lincRNA) gene, meaning it produces an RNA transcript over 200 nucleotides in length that does not code for a protein and does not overlap nearby protein-coding genes[1][3][5]. LINC00272 is part of the broader class of long non-coding RNAs, which are known to regulate gene expression, chromatin state, and other cellular processes primarily by acting as molecular scaffolds or guides to influence the activity of regulatory complexes[3][5]. Although the general class of lincRNAs is associated with a range of biological roles and disease associations (including cancer)[5], there is currently no direct evidence in the provided results that LINC00272 itself is a validated therapeutic target, a biomarker, or a focus of drug interaction studies. It is primarily classified as a regulatory non-coding RNA with possible, but undefined, roles in gene regulation[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 272 (LINC00272).